Loading provider…
Loading provider…
Nephrology Physician in New York, NY
NPI: 1306918651Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Trustees of Columbia University in the City of New York
columbiadoctors.org
HQ Phone
Get M.D. Gerald's Phone Numberphone_androidMobile
Get M.D. Gerald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2021
NJ State Medical License
2022 - 2027
NY State Medical License
1973 - 2026
CT State Medical License
2022 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
New York Presbyterian Hospital (Columbia Campus)
Residency • Internal Medicine
1972 - 1976
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 1972
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 117 | 256 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 14 | 14 |
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
Authors: Duvuru Geetha, Cornelis Kallenberg, John H. Stone, Alan D. Salama, Gerald B. Appel, George Duna, Paul Brunetta, David Jayne
Publication Date: 2015-02
Proliferative Glomerulonephritis with Monoclonal IgG Deposits
Authors: Anthony Valeri
Publication Date: 2009-09
Filgrastim–Induced Crescentic Transformation of Recurrent IgG2λ GN
Authors: Markus Mapara, Ibrahim Batal
Publication Date: 2016-07
Lead Sponsor: Columbia University
Collaborators: Alexion Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Eculizumab
Lead Sponsor: Columbia University
Collaborators: Mallinckrodt
Intervention / Treatment: DRUG: ACTHAR gel
Lead Sponsor: Mayo Clinic
Collaborators: Genentech, Inc., Biogen, Stanford University, Columbia University, Ohio State University, University of North Carolina, Chapel Hill
Intervention / Treatment: DRUG: ACE/ARB, DIETARY_SUPPLEMENT: Omega-3 Fatty Acid Fish Oil Supplement, DRUG: Intravenous Rituximab